{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:26:41Z","timestamp":1778261201612,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,21]]},"DOI":"10.7759\/cureus.58680","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T12:48:10Z","timestamp":1713703690000},"source":"Crossref","is-referenced-by-count":2,"title":["Poor Glycemic Control Affecting Screening of Prostate Carcinoma"],"prefix":"10.7759","author":[{"given":"Archana","family":"Bharti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","volume":"10","author":"Kivimaki M","year":"2022","unstructured":"Kivimaki M, Strandberg T, Pentti J, et al.. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Diabetes and Endocrinology. 2022, 10:253-63.","journal-title":"Diabetes and Endocrinology"},{"key":"ref2","article-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients","volume":"23 Suppl 2","author":"Shichiri M","year":"2000","unstructured":"Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000, 23 Suppl 2:B21-9.","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb S","year":"2014","unstructured":"Loeb S, Bjurlin MA, Nicholson J, et al.. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014, 65:1046-55. 10.1016\/j.eururo.2013.12.062","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/iju.iju_232_22","article-title":"The Urological Society of India guidelines for the evaluation and management of prostate cancer","volume":"38","author":"Kumar A","year":"2022","unstructured":"Kumar A, Yadav S, Krishnappa RS, et al..  The Urological Society of India guidelines for the evaluation and management of prostate cancer. Indian J Urol. 2022, 38:252-7. 10.4103\/iju.iju_232_22","journal-title":"Indian J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei JT","year":"2023","unstructured":"Wei JT, Barocas D, Carlsson S, et al.. Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening. J Urol. 2023, 210:46-53. 10.1097\/JU.0000000000003491","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00638-6","article-title":"Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future","volume":"19","author":"Van Poppel H","year":"2022","unstructured":"Van Poppel H, Albreht T, Basu P, Hogenhout R, Collen S, Roobol M. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol. 2022, 19:562-72. 10.1038\/s41585-022-00638-6","journal-title":"Nat Rev Urol"},{"key":"ref7","article-title":"Prostate specific antigen","author":"David MK","year":"2023","unstructured":"David MK, Leslie SW. Prostate specific antigen. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref8","article-title":"Prostate cancer screening","author":"Jain MA","year":"2023","unstructured":"Jain MA, Leslie SW, Sapra A. Prostate cancer screening. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12318","article-title":"American Urological Association (AUA) guideline on prostate cancer detection: process and rationale","volume":"112","author":"Carter HB","year":"2013","unstructured":"Carter HB. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale. BJU Int. 2013, 112:543-7. 10.1111\/bju.12318","journal-title":"BJU Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12954\/PI.14054","article-title":"Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice","volume":"2","author":"Lojanapiwat B","year":"2014","unstructured":"Lojanapiwat B, Anutrakulchai W, Chongruksut W, Udomphot C. Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice. Prostate Int. 2014, 2:133-9. 10.12954\/PI.14054","journal-title":"Prostate Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0055-4","article-title":"Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer","volume":"118","author":"Murtola TJ","year":"2018","unstructured":"Murtola TJ, Vihervuori VJ, Lahtela J, Talala K, Taari K, Tammela TL, Auvinen A. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. Br J Cancer. 2018, 118:1248-54. 10.1038\/s41416-018-0055-4","journal-title":"Br J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225735","article-title":"Diabetes and cancer: risk, challenges, management and outcomes","volume":"13","author":"Shahid RK","year":"2021","unstructured":"Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers (Basel). 2021, 13:10.3390\/cancers13225735","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.22037\/uj.v16i7.5645","article-title":"The influences of metformin on prostate in terms of PSA level and prostate volume","volume":"18","author":"Atalay E","year":"2020","unstructured":"Atalay E, Demir A, Eroglu HA. The influences of metformin on prostate in terms of PSA level and prostate volume. Urol J. 2020, 18:181-5. 10.22037\/uj.v16i7.5645","journal-title":"Urol J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-SINT","article-title":"Introduction and methodology: Standards of Care in Diabetes-2024","volume":"47","year":"2024","unstructured":"Introduction and methodology. Standards of Care in Diabetes-2024. Diabetes Care. 2024, 47:S1-4. 10.2337\/dc24-SINT","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01064-k","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo Y","year":"1995","unstructured":"Ohkubo Y, Kishikawa H, Araki E, et al.. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995, 28:103-17. 10.1016\/0168-8227(95)01064-k","journal-title":"Diabetes Res Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00092.x","article-title":"The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes","volume":"48","author":"King P","year":"1999","unstructured":"King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999, 48:643-8. 10.1046\/j.1365-2125.1999.00092.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2012.07.008","article-title":"Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence","volume":"30","author":"Pierce BL","year":"2012","unstructured":"Pierce BL. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. Urol Oncol. 2012, 30:735-43. 10.1016\/j.urolonc.2012.07.008","journal-title":"Urol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-018-1067-3","article-title":"The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer","volume":"29","author":"Miller EA","year":"2018","unstructured":"Miller EA, Pinsky PF, Pierre-Victor D. The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer. Cancer Causes Control. 2018, 29:907-14. 10.1007\/s10552-018-1067-3","journal-title":"Cancer Causes Control"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj311","article-title":"Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002","volume":"164","author":"Werny DM","year":"2006","unstructured":"Werny DM, Saraiya M, Gregg EW. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol. 2006, 164:978-83. 10.1093\/aje\/kwj311","journal-title":"Am J Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1962","article-title":"Serum prostate-specific antigen levels in men with type 2 diabetes","volume":"31","author":"Fukui M","year":"2008","unstructured":"Fukui M, Tanaka M, Kadono M, Imai S, Hasegawa G, Yoshikawa T, Nakamura N. Serum prostate-specific antigen levels in men with type 2 diabetes. Diabetes Care. 2008, 31:930-1. 10.2337\/dc07-1962","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0145","article-title":"Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis","volume":"59","author":"Bernal-Soriano MC","year":"2020","unstructured":"Bernal-Soriano MC, Lumbreras B, Hern\u00e1ndez-Aguado I, Pastor-Valero M, L\u00f3pez-Garrigos M, Parker LA. Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis. Clin Chem Lab Med. 2020, 59:11-26. 10.1515\/cclm-2020-0145","journal-title":"Clin Chem Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.08.115","article-title":"Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes","volume":"193","author":"Sarma AV","year":"2015","unstructured":"Sarma AV, Hotaling J, Dunn RL, et al.. Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. J Urol. 2015, 193:786-93. 10.1016\/j.juro.2014.08.115","journal-title":"J Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041287","article-title":"Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target","volume":"15","author":"Liu G","year":"2023","unstructured":"Liu G, Zhu M, Zhang M, Pan F. Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target. Cancers (Basel). 2023, 15:10.3390\/cancers15041287","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.4.1383255","article-title":"Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma","volume":"75","author":"Cohen P","year":"1992","unstructured":"Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 1992, 75:1046-53. 10.1210\/jcem.75.4.1383255","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14689","article-title":"Association between antidiabetic medications and prostate-specific antigen levels and biopsy results","volume":"2","author":"Beckmann K","year":"2019","unstructured":"Beckmann K, Crawley D, Nordstr\u00f6m T, et al.. Association between antidiabetic medications and prostate-specific antigen levels and biopsy results. JAMA Netw Open. 2019, 2:e1914689. 10.1001\/jamanetworkopen.2019.14689","journal-title":"JAMA Netw Open"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0910-y","article-title":"The association of diabetes with risk of prostate cancer defined by clinical and molecular features","volume":"123","author":"Feng X","year":"2020","unstructured":"Feng X, Song M, Preston MA, et al.. The association of diabetes with risk of prostate cancer defined by clinical and molecular features. Br J Cancer. 2020, 123:657-65. 10.1038\/s41416-020-0910-y","journal-title":"Br J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/248066-poor-glycemic-control-affecting-screening-of-prostate-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T12:48:14Z","timestamp":1713703694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/248066-poor-glycemic-control-affecting-screening-of-prostate-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.58680","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,21]]}}}